Renal Podocyte Injury in a Rat Model of Type 2 Diabetes Is Prevented by Metformin

Oxidative and Nitrosative Stress and Progression of Diabetic Nephropathy in Type 2 Diabetes

(2010) Hideki Fujii et al.   AMERICAN JOURNAL OF NEPHROLOGY

Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state

(2010) Marc Foretz et al.   JOURNAL OF CLINICAL INVESTIGATION

Review: Metformin: Potential benefits and use in chronic kidney disease

(2010) HELEN L PILMORE   NEPHROLOGY

Diabetic cardiomyopathy: effects of fenofibrate and metformin in an experimental model – the Zucker diabetic rat

(2009) Fabien Forcheron et al.   Cardiovascular Diabetology

Induction of heme oxygenase-1 protects against podocyte apoptosis under diabetic conditions

(2009) Sang Choel Lee et al.   KIDNEY INTERNATIONAL

Diabetes-Associated Complications in Spontaneously Diabetic Torii Fatty Rats

(2008) Kenichi MATSUI et al.   EXPERIMENTAL ANIMALS

The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats

(2007) Zheng Liu et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Thromboxane Receptor Activates the AMP-Activated Protein Kinase in Vascular Smooth Muscle Cells via Hydrogen Peroxide

(2007) Miao Zhang et al.   CIRCULATION RESEARCH